Vironix Heart Failure Manuscript Published In The Journal Of Cardiovascular Translational Research
Our manuscript about heart failure was recently published in the Journal of Cardiovascular Translational Research. This is a highly respected peer reviewed journal on cardiovascular research. JCTR is the journal of choice for professionals seeking information about emerging technologies, therapies and diagnostics, preclinical research, and first-in-man clinical trials.
Vironix is chosen to participate in the 2021 MassChallenge Accelerator
We are pleased to announce that Vironix was chosen to participate in the 2021 MassChallenge Accelerator. This is an amazing opportunity for us to work with the team members at MassChallenge. MassChallenge is a non-profit organization dedicated to supporting innovation and entrepreneurship through collaboration and development.
Vironix discusses chronic lung diseases at the 2021 University Of Vermont MPI Workshop
Vironix team members attended the 2021 University Of Vermont MPI Workshop on June 14th - 18th.
Vironix Health attends Arab Health 2021
Vironix Health attended the 2021 Arab Health Conference in Dubai, United Arab Emirates - June 21st through June 24th. Arab Health is the largest gathering of healthcare companies, technology, products and services in the MENA region. Arab Health’s slogan is: “Where the healthcare world comes to do business.”
Vironix presents Covid-19 solution at the American Thoracic Society conference
Team members of Vironix Health presented their Covid-19 solution at the 2021 American Thoracic Society International Conference that was held May 14th - 19th. The Vironix approach is a highly novel, generalizable methodology for mapping clinical characteristic data into patient scenarios for the purpose of training machine-learning prediction models to detect health deterioration due to viral illness. Vironix solution exhibits excellent accuracy, sensitivity, and specificity in identifying and triaging clinical presentations of Covid-19 and the most appropriate level of medical urgency. Read the entire paper - Click Here
Digital Health, the Future of Pharma, and Diversity in Healthcare. An interview with Georgia Mitsi, VP of Strategic Partnerships at Penumbra
Georgia Mitsi, VP of Strategic Partnerships at Penumbra, talks about the role digital health is playing during the Covid pandemic, and how to move the needle regarding diversity & inclusion in our healthcare companies.
Vironix Selected To Participate In The 2021 SparkHealth Accelerator
20Fathoms has chosen the 10 digital and telehealth companies selected to participate in the 2021 cohort of the HealthSpark Accelerator. Vironix is happy to announce that it was selected to participate in the 2021 SparkHealth Accelerator program. Vironix will gain insightful information in the areas of:
Vironix Health has teamed up with Oxford University to develop novel algorithms to remotely detect and distinguish Flu-like illness & Covid-19.
PRESS RELEASE - February 24th, 2021 (PR Newswire)
Former Anthem and Truven Executive Mahesh Visvanathan Joins Vironix Health as Chief Operations and Business Development Officer
Mahesh will lead new partnership development and commercialization efforts to expand Vironix’s cloud API and enterprise software businesses.